General MedicationsORALStandard
VEOZAH
FEZOLINETANT
Standard Dose
45MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VEOZAH is listed in Drugs@FDA under application 216578 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FEZOLINETANT Form and strength TABLET;ORAL - 45MG Sponsor ASTELLAS Submission history Latest submission status date: 2024-12-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview VEOZAH is listed in Drugs@FDA under application 216578 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FEZOLINETANT Form and strength TABLET;ORAL - 45MG Sponsor ASTELLAS Submission history Latest submission status date: 2024-12-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.